Copyright
©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. May 6, 2016; 7(2): 179-189
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.179
Published online May 6, 2016. doi: 10.4292/wjgpt.v7.i2.179
Figure 1 EsophyX® device: First and second generation devices (courtesy of EndoGastric Solutions, Inc.
Redmond, WA, United States). A1-A2: The device currently used (©2014 EndoGastric Solutions, Inc); B1-B2: The new generation device (©2014 EndoGastric Solutions, Inc).
- Citation: Testoni PA, Mazzoleni G, Testoni SGG. Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomes. World J Gastrointest Pharmacol Ther 2016; 7(2): 179-189
- URL: https://www.wjgnet.com/2150-5349/full/v7/i2/179.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i2.179